Atlas Trials

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Clinical trial NCT02395978 · COMPLETED

Trial details

NCT number
NCT02395978
Sponsor
BioLite, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2015-04-10
Primary completion
2019-03-12
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.